Elevance Health
ELV • NYSE
Elevance Health is a medical - healthcare plans company in the healthcare sector trading on NYSE, led by CEO Gail Koziara Boudreaux, with a market cap of $75.7B.
CEOGail Koziara Boudreaux
Market Cap$75.7B
Medical - Healthcare Plans
Healthcare
Employees104.9K
Websiteelevancehealth.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Elevance Health
Date
Tuesday, April 21, 2026 (in 2 months)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$10.50
Revenue Estimate
$48.6B
Earnings History
Past 12 earnings reports for Elevance Health
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Jan 28, 2026 | Q4 2025 | $3.33Est: $3.10 | +7.4% | $49.3BEst: $49.5B | -0.3% |  10-K |
| Oct 21, 2025 | Q3 2025 | $6.03Est: $4.96 | +21.6% | $50.1BEst: $49.5B | +1.2% | — |
| Jul 17, 2025 | Q2 2025 | $8.84Est: $9.19 | -3.8% | $49.4BEst: $48.2B | +2.5% | 10-Q |
| Apr 22, 2025 | Q1 2025 | $11.97Est: $11.38 | +5.2% | $48.8BEst: $46.3B | +5.3% | 10-Q |
| Jan 23, 2025 | Q4 2024 | $3.84Est: $3.86 | -0.5% | $45.0BEst: $44.7B | +0.6% | 10-K |
| Oct 17, 2024 | Q3 2024 | $8.37Est: $9.66 | -13.4% | $44.7BEst: $43.3B | +3.2% | 10-Q |
| Jul 17, 2024 | Q2 2024 | $10.12Est: $10.01 | +1.1% | $43.2BEst: $43.1B | +0.4% | 10-Q |
| Apr 18, 2024 | Q1 2024 | $10.64Est: $10.53 | +1.0% | $42.3BEst: $42.6B | -0.8% | 10-Q |
| Jan 24, 2024 | Q4 2023 | $5.62Est: $5.64 | -0.4% | $42.5BEst: $42.1B | +0.9% | 10-K |
| Oct 18, 2023 | Q3 2023 | $8.99Est: $8.45 | +6.4% | $42.5BEst: $42.5B | -0.1% | 10-Q |
| Jul 19, 2023 | Q2 2023 | $9.04Est: $8.80 | +2.7% | $43.4BEst: $41.5B | +4.5% | — |
| Apr 19, 2023 | Q1 2023 | $9.46Est: $9.26 | +2.2% | $41.9BEst: $40.8B | +2.6% | — |